Trokendi Xr 17772-0104
Generic: Topiramate
Product NDC
17772-0104- Manufacturer
- Supernus Pharmaceuticals, Inc.
- Dosage Form
- Capsule, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 16, 2013
- Listing Expires
- December 31, 2027
- Application
- NDA201635
Need to source Trokendi Xr? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Topiramate | 200 mg/1 |
Drug Class
Cytochrome P450 2C19 Inhibitors [MoA]Cytochrome P450 3A4 Inducers [MoA]Decreased Central Nervous System Disorganized Electrical Activity [PE]
Packaging Options(5)
100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-104-01)
7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-104-07)
5 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (17772-104-10)
7 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (17772-104-12)
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-104-30)